Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Development and commercialization of gene therapies to treat an array of diseases83.33M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
Other36.66M44.00%
United States30M36.00%
United Arab Emirates8.33M10.00%
Germany8.33M10.00%